Article Text

Download PDFPDF

Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial
  1. K C H Fearon1,
  2. M F von Meyenfeldt2,
  3. A G W Moses1,
  4. R van Geenen3,
  5. A Roy4,
  6. D J Gouma3,
  7. A Giacosa5,
  8. A Van Gossum6,
  9. J Bauer7,
  10. M D Barber1,
  11. N K Aaronson8,
  12. A C Voss9,
  13. M J Tisdale10
  1. 1Royal Infirmary of Edinburgh, Edinburgh, UK
  2. 2University Hospital of Maastricht, Maastricht, the Netherlands
  3. 3Academisch Medisch Centrum, Amsterdam, the Netherlands
  4. 4Centre Hospitalier de l’University de Montreal, Montreal, Canada
  5. 5Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
  6. 6Universite de Bruxelles Erasme, Brussels, Belgium
  7. 7The Wesley Hospital, Brisbane, Australia
  8. 8Antonie van Leeuwen Hoek Ziekenhuis, Amsterdam, the Netherlands
  9. 9Ross Products Division, Abbott Laboratories, Columbus, Ohio, USA
  10. 10Aston University, Birmingham, UK
  1. Correspondence to:
    Professor K C H Fearon, Department of Clinical and Surgical Sciences (Surgery), Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh EH16 4SA, UK;
    k.fearon{at}ed.ac.uk

Footnotes

  • Conflict of interest: A C Voss is an employee of Ross Products Division, Abbott Laboratories.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Conflict of interest: A C Voss is an employee of Ross Products Division, Abbott Laboratories.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles